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ABSTRACT
Infection with herpes simplex virus type 1 leads to a lifelong presence of the vims 
in the host typified by the punctuated recrudescence of herpetic lesions of the orofacial 
region. Recmdescence of symptoms is due to the ability of the virus to reactivate from a 
latent state in neurons of the trigeminal ganglia. The latent state characterized by a 
complete lack of DNA replication, absence of virion stmctural protein production, and 
the minimal expression of a very limited set of regulatory genes. Reactivation is seen as 
the return to full viral gene expression, production of new infectious virions, and the 
emergence of clinical symptoms of herpetic disease. The viral transactivator ICPO has 
been implicated in both latency and reactivation. PC 12 cells neurally differentiated by 
nerve growth factor were used as host cells to attempt to generate a quiescent infection. A 
viral construct deletion mutant GHSV-UL46 that lacks the ICP4 transactivator genes, has 
a defective US3, and has green fluorescent protein gene attached to gene UL46 was used. 
Roscovitine, a small molecule inhibitor of cyclin dependent kinases, was used for its 
ability to prevent ICPO activity via prevention of ICPO’s phosphorylation by cyclin- 
dependent kinase 5. Inhibition of ICPO transactivity with roscovitine did not shift 
expression equilibrium towards latency. The use of an inhibitor of MEK1, PD98059, 
however, showed better inhibition of GFP expression than either roscovitine or acyclovir. 
The data indicates that a low-level productive infection was achieved as opposed to a 
quiescent infection, while studies of small molecule inhibitors posit the possibility that 
the molecular events of a low-level productive infection differ from those of a fully 
productive infection.
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INTRODUCTION
Herpes simplex virus type 1 (HSV-1) belongs to a family of DNA viruses that are 
capable of establishing a lifelong infection in their hosts by entering into a latent state 
that is characterized by a lack of replication of viral DNA genome and extremely limited 
transcription of a small set of genes. HSV-Ts biphasic lifestyle begins with a lytic 
infection of epithelial cells (typically oral) that produces new virions that proceed into 
nearby neurons (Cook, Bastone and Stevens 1974; Stevens et al. 1987) via retrograde 
axonal transport, where a latent state ultimately results (Stevens 1975). A return to 
productive activity from latency is termed reactivation, and occurs periodically in 
neurons that receive a variety of stressful stimuli, among them physical (Valyi-Nagi et al. 
1991), radioactive (Laycock et al. 1991), and hyperthermic (Halford, Gephart and Carr 
1996) stresses.
The genome of HSV-1 can be organized into three gene categories with each 
category activated after another in a temporal cascade during infection (Honess and 
Roizman 1974). The first five genes to be expressed when the virus enters a permissive 
cell are termed the immediate-early (IE) genes (Honess and Roizman 1974; Pereira et al. 
1977; Purifoy and Powell 1976). IE genes express products that function as 
transactivators and repressors that up- and downregulate the early (E) and late (L) genes, 
as well as the IE genes themselves. Viral protein 16 (VP16), a protein that is packaged 
within the virion (Batterson and Roizman 1983; Post, Mackem and Roizman 1981) 
activates the expression of the IE genes upon infection (Campbell, Palfreyman and 
Preston 1984). The E genes code for replicative and immune modulating enzymes. The L 
genes code for viral structural proteins. The E and L genes are only expressed during a
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productive infection and are largely silenced in latency (Ward and Roizman 1994). The 
latent phase itself is characterized in part by the abundant presence of alternatively 
spliced mRNAs termed latency-associated-transcripts (LATs; Deatly et al. 1987; Stevens 
et al. 1987). Initially it was thought that viral gene expression during latency was limited 
to the LATs, but more sensitive assays have shown that low levels of the IE gene 
products infected cell polypeptide (ICP) 0 and ICP4, as well as the E gene products ICP6 
(viral ribonucleotide reductase) and the viral thymidine kinase are also present during 
latent infection (Chen et al. 2002; Kramer and Coen 1995; Tal-Singer et al. 1997).
ICPO and ICP4 are products of IE genes that regulate the activity of the rest of the 
HSV-1 genome. ICPO is a promiscuous transactivator if the viral genome that also has 
been shown to interact with cellular proteins (Jordan and Schaffer 1997). It has been 
shown that overexpression of ICPO in latently infected cells is sufficient for reactivation 
(Mavromara-Nazos et al. 1986). However, controversy exists as to how central the role of 
ICPO is in latency and reactivation: work done on mouse and rabbit latency models have 
shown ICPO to be necessary for efficient reactivation (Honess and Roizman 1984), but 
work done on cultured cells has resulted in contrary data suggesting its non-necessity 
(Miller 2006). ICP4 is also a transactivator of E and L genes (Gelman and Silverstein 
1986), but interestingly also has the ability to function as a repressor of itself and as well 
as ICPO (Lee and Schaffer 1998; Michael and Roizman 1993). When ICPO and ICP4 are 
both present, an apparent synergism occurs that appears to bolster their transactivating 
activity some 20 times more than the activity of either alone (Everett 1984; Gelman and 
Silverstein 1986).
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Recently, experimental support has been given to a hypothesis that suggests ICPO 
complexes with ICP4, and the resulting ICP0-ICP4 complex represses the expression of 
ICP4 gene in a manner reminiscent of the bacteriophage A, repressor/antirepressor switch 
that regulates lysogenic and lytic cycles (Liu et al. 2010). The report showed that ICP4 
functions as the repressor that prevents the expression of ICPO, thereby shifting the 
kinetic equilibrium towards latency. If ICPO accumulates either by a high multiplicity of 
infection (MOI) or by being transactivated in some other way that bypasses ICP4’s 
silencing activity, then the complexing of ICPO with ICP4 eliminates ICP4’s repressive 
activity, allowing more ICPO to be produced and shifting the virus towards a productive 
infection. Thus, ICPO functions as the antirepressor.
To further investigate this relationship, the PC 12 cell system was employed, 
which has been shown to be able to support a latent-like HSV-1 infection, termed 
“quiescence” in cell culture to distinguish it from in vivo models (Danaher et al. 1999; 
Danaher, Jacob and Miller 1999; Danaher et al. 2008; Miller, Danaher and Jacob 2006; 
Miller et al,. 2003; Su et al. 1999; Su et al. 2000; Su et al. 2002). PC 12 cells were 
originally harvested from a rat pheochromocytoma (cancer of adrenal tissue) tumor and 
cultured (Greene and Tischler 1976). As with the cancerous phenotype of other cells, 
these cells exist in a partially undifferentiated state. Originating in development from the 
neural crest, these cells can either be induced to differentiate into chromaffin cells or 
neurons. PC 12 cells will assume partial neuronal phenotypes with the addition of nerve 
growth factor (NGF) to culture medium. Neurally-differentiated (ND) phenotypes include 
the formation of long neuritic processes that can carry action potentials, the cessation of 
mitotic activity, the synthesis, storage, uptake and release of catecholamines, and other
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biochemical properties in common with peripheral neurons (Greene 1978; Greene and 
Tischler 1976). Using the PC 12 cell system provides for a renewable and homogeneous 
cell population that is difficult to obtain in tissue culture or in vivo explant models.
Quiescently infected (QIF) ND-PC12 (QIF-PC12) cells are defined by their 
ability to persist in culture for weeks without the detectable presence of virus after an 
initial brief productive period immediately following infection. Reactivation and recovery 
of infectious virus can be performed at any time during the quiescent period using heat or 
chemical agents (Danaher, Jacob and Miller 1999; Danaher et al. 1999). The QIF-PC12 
model has been shown to produce results that are comparable to those seen in vivo: the 
circularization of the HSV-1 genome upon infection occurs in QIF-PC12 cultures (Su et 
al. 2002) as it does in vivo (Efstathiou et al. 1986, Rock and Fraser 1983), a 10 day 
treatment of acyclovir (ACV) establishes quiescence in infected ND-PC12 cultures 
(Danaher, Jacob, and Miller 1999) as it does in vivo (Wilcox and Johnson 1988), 
forskolin treatment causes reactivation in QIF-PC12 cultures (Danaher, Jacob, and Miller 
1999) as it does in vivo (Smith et al. 1992), reactivation occurs in a minority of cells in 
QIF-PC12 cultures (Danaher et al. 1999) as it does in vivo (Sawtell and Thompson 1992), 
comparable numbers of viral genomes exist within cells of QIF-PC12 cultures as cells of 
tissue explants (Miller et al. 2003), and similarity of reactivation efficiencies after 
establishment of a quiescent infection using respective wild type and mutant viruses 
(Miller et al. 2003).
The virus used was GHSV-UL46, a recombinant mutant with a number of 
modifications that made it suitable for this study (Willard 2002). GHSV-UL46 is derived 
from mutant dl 20, which itself is a deletion mutant derived from wild-type strain KOS
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that has the ICP4 genes deleted and a defective US3 gene (DeLuca, McCarthy and 
Shaffer 1985). dl20 has been shown to be a potent inducer of apoptosis in the dividing 
cell lines: Vero, SK-N-SH, Hep-2, and HEL (Galvan, Brandimarti and Roizman 1998; 
Galvan and Roizman 1999; Leopardi and Roizman 1996; Leopardi, Van Sant and 
Roizman 1997; Munger, Chee and Roizman 2001; Zhou and Roizman 2000) due to its 
defective US3, a gene that functions in the prevention of apoptosis (Benetti, Munger and 
Roizman 2003; Benetti and Roizman 2004; Jerome et al. 1999). It has previously been 
shown that dl20 does not induce widespread apoptosis in ND-PC12 cells as it does in 
dividing cell lines (Aiamkitsumrit et al. 2007).
GHSV-UL46 differs from d 120 in that it has the green fluorescent protein (GFP) 
gene inserted into gene UL46 that codes for a major tegument protein, allowing for direct 
visualization of the virus within cells using fluorescence microscopy (Willard 2002). 
Since GFP is expressed as part of the structural tegument proteins which fall under the L 
temporal category, virus will be seen only in cells that are actively producing new virions 
as part of a productive infection. This attribute makes GHSV-UL46 an ideal candidate for 
latency studies.
Curiously, it has been shown that another ICP4 deletion mutant, KD6, completely 
failed to reactivate in QIF-PC12 cells after chemical and heat stress (Miller, Danaher and 
Jacob 2006). Due to the repressor/antirepressor relationship of ICP4 and ICP0 suggested 
earlier (Liu et al. 2010), one would assume that abundant levels of ICP0 that go 
unrepressed by ICP4 would either prevent the establishment of quiescence altogether or 
render a quiescently-infected cell much more sensitive to reactivation.
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The small molecule inhibitor roscovitine (Rosco) inhibits the transactivating 
activity of ICPO (Davido, Leib and Schagger 2002), possibly by interfering with ICPO’s 
post-translational modifications (Advani et al. 2001; Schang, Rosenberg, and Schaffer 
1999). Rosco selectively and potently inhibits cyclin-dependent kinases cdkl, cdk2, cdk5 
(Meijer et al. 1997). Since mutant viruses lacking ICPO have been shown to be 
complemented by cellular activity occurring in the late Gi/S phase of the cell cycle such 
as that of the cdk’s (Cai and Schaffer 1991), it would be reasonable to hypothesize that 
the inhibitory effect of Rosco on ICPO is through direct inhibition of one or more of the 
cdk’s that ICPO is dependent on and that are affected by Rosco, as opposed to direct 
inhibition of the ICPO protein itself. This makes Rosco a potential candidate for use in 
seeking out more specific mechanisms by which an absence of ICPO (due to 
transcriptional repression by ICP4) facilitates the establishment of latency and, later, 
reactivation. In this way, Rosco is being explored as a semi-complement for ICP4’s 
repressor activity that is absent in the mutant virus. Since repression of ICPO by ICP4 
results in a global nullification of ICPO-induced events, then Rosco could potentially, 
after additional testing, be used as a targeted approach that removes some or all of ICPO’s 
activity while still allowing ICPO to remain in the cell. Since the mechanism of inhibition 
of Rosco is known, the role of ICPO, ICP4, and host factors in the establishment of 
latency and induction of reactivation can be further explored. The purpose of this study is 
to examine the productive versus quiescent activity of GHSV-UL46 in the context of the 
ND-PC12 model. Additionally, this study seeks to reveal if Rosco-treated ND-PC12 cells 
infected with GHSV-UL46 will respond to reactivation stimuli in a wild-type manner as 
established by literature despite their lack of ICP4.
6
REVIEW of LITERATURE
Herpes simplex vims type 1 (HSV-1) belongs to a family of DNA viruses that are 
capable of establishing a lifelong infection in their hosts by entering into a latent state 
that is characterized by a lack of replication of its DNA genome and extremely limited 
transcription of a small set of genes. HSV-Ts biphasic lifestyle begins with a lytic 
infection of epithelial cells (typically oral) that proceeds into nearby neurons (Cook, 
Bastone and Stevens 1974) via retrograde axonal transport, where a latent state ultimately 
results (Stevens 1975). A return to productive activity from latency is termed 
reactivation, and occurs periodically in neurons that receive a variety of stressful stimuli, 
among them physical (Valyi-Nagi et al. 1991), radioactive (Laycock et al. 1991), and 
hyperthermic (Halford, Gephart and Carr 1996) stress.
Difficulties in understanding HSV-1 latency and reactivation partially stem from 
the lack of a convenient neuronal cell-line for which to study the events that occur on a 
molecular level. When animal models are used, problems include: heterogeneity of viral 
strains making it difficult to characterize infections, heterogeneity of harvested tissue that 
may have other permissive or non-permissive cell types that may distort the perception of 
latency, and host immune interactions interfering with observation of strictly virus-cell 
interactions. Tissue culture systems provide some solutions but come with their own 
problems, specifically the need to remove tissue from an animal system which, again, 
may come with a variety of uncontrolled variables, including the stress that the animal 
experiences. Cell culture then becomes an efficient alternative that may make up for what 
it lacks in similarity with the in vivo systems with its relative ease of use and superior 
control of exogenous variables, although it is not a perfect system as it is conducted under
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artificial environments that lack many of the characteristics of true physiological 
conditions. Consequently, the homogeneity of cell populations offered by cell culture 
may also be disadvantageous because interactions with other cell types may strongly 
influence the intracellular activity of viruses.
One such culture system is the PC 12 cell system. PC 12 cells were originally 
harvested from a rat pheochromocytoma (cancer of adrenal tissue) tumor and cultured 
(Greene and Tischler 1976). Originating in development from the neural crest, these cells 
can either be induced to differentiate into chromaffin cells or assume neuronal-like 
phenotypes. PC 12 cells will assume partial neuronal phenotypes with the addition of 
nerve growth factor (NGF) to culture medium. Phenotypes include the formation of long 
neuritic processes that can carry action potentials, the cessation of mitotic activity, the 
synthesis, storage, uptake and release of catecholamines, and other biochemical 
properties in common with peripheral neurons. (Greene 1978; Greene and Tischler 1976). 
Caution must be taken in interpreting data gathered by using this cell system with HSV-1, 
however, as the primary sites of HSV-1 latency are sensory neurons and ND-PC12 cells 
resemble sympathetic neurons.
Attempts at setting up a long-term latent-like infection in ND-PC12 cells began 
in earnest with the work of Block et al. (1994), although with some minor setbacks. This 
is the work that would serve as a foundation of more efficient ND-PC12 models for 
latency in the future. Cells were plated in the presence of NGF as well as horse serum and 
fetal bovine serum. Replacing medium every 3 days, after 2 weeks more than 90% of 
cells had visible neurite extensions. The researchers make special note of the observation 
that adding NGF seems to cause a 50% loss of the cell population and propose that this
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may be due to clumping and detachment. After this 2 week period of differentiation, 
infection was carried out with HSV-1 strain 17. Within 1 week, 30% of the remaining 
cells were lost, but the neuronal morphology of remaining cells seemed to be unaffected. 
The researchers reported that there was an initial 10 day surge in virus titer which then 
dropped off beneath the level of detection after about 2 weeks. At 24 days post-infection 
while virus titers were still less than 1,000 PFU per 75 mm2 flask, the NGF was removed 
from the medium. Within 1 day, virus titers in medium increased 100-fold, confirming a 
previous observation that NGF is inhibitory to reactivation (Leib et al. 1991).
Running in parallel to the NGF-deprivation experiment were infected ND-PC12 
cultures maintained for four weeks without clear morphological differences to uninfected 
cells and low or undetectable levels of virus in media. To see if these cells still harbored 
virus in a latent state, the cells were seeded onto CV-1 cell monolayers in order to 
perform an infectious center assay. Rabbit antibodies to HSV-1 were used when ND- 
PC12 cells were harvested to ensure any virus present came from an infected ND-PC12. 
Upon seeding onto the CV-1 monolayers, ND-PC12 cells began releasing virus and the 
number of CV-1 plaques corresponded to the number of ND-PC12 cells seeded, showing 
that most ND-PC12 cells harbored latent virus (Block et al. 1994).
Block et al. (1994) went on further to see if the structure of the HSV-1 genome 
was non-linear in ND-PC12 cells as it was found to be in latently infected neurons of 
mice. Restriction enzyme analysis strongly suggested that viral DNA isolated from long­
term infected ND-PC12 cells was non-linear, while virion DNA and productively- 
infected cell (CV-1) DNA was linear. Implied is that HSV-1 DNA exists either as a
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circular concatamer or integrated into the host chromosome(s). This result, thus, is that 
which would be expected from a latent infection of true neurons.
Assessments were carried out to detect the presence of latency-associated 
transcripts (LATs). LATs are mRNAs that are ubiquitously found in latently infected 
cells (Stevens et al. 1987) but have not been shown to code for proteins. In this way, 
LATs are telltale markers of latency. Block et al. used probes to detect LAT RNA via in 
situ hybridization in their long-term infected ND-PC12 populations. Probes to the 
glycoprotein (g)C transcript, a late gene only transcribed during lytic infection (Deatly et 
al. 1987), were also used. The results of these experiments were that gC was not detected 
in any cells, but LATs were detected in only 1% of cells. The cells that showed LATs 
were those on the periphery of cell clusters. Researchers puzzled over the results of the 
infectious center assay showing 100% of cells being latently infected while LATs were 
only detected in 1%. Even though this finding conflicted with the findings of LAT 
detection in in vivo systems, researchers concluded that the PC 12 system was comparable 
to in vivo for studying HSV-1 latency by virtue of similarities in viral DNA structure and 
limited transcription (Block et al. 1994).
Jordan, Pepe and Schaffer (1998) utilized the PC 12 cell system for the study of 
HSV-1 latency, but did not engineer a quiescent infection. The hypothesis was posed that 
some cellular activity substitutes for the transactivation activity of the viral product ICPO. 
A product of the IE gene suite, ICPO functions as a broad transactivator of all other viral 
genes during productive infection and also shows activity for other cellular promoters 
(Jordan and Schaffer 1997). Using the PC 12 cell model and «212, an HSV-1 deletion 
mutant lacking ICPO, the growth factors NGF and fibroblast growth factor (FGF) were
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tested for the suspected cellular activity that could replace the activity in the ICPO- 
deficient mutant.
The ICPO-null mutant virus «212 is replication deficient because of its deletion. 
Cells were infected with «212 and wild-type virus KOS for comparison, and then treated 
with growth factors. Results showed that NGF and FGF, hormones that induce the 
morphological differentiation of PC 12 cells, could increase the amount of infectious virus 
released from cells in both strains of virus, but the effect was some 4-5 times greater in 
«212. Epidermal growth factor (EGF), a hormone that induces proliferation in PC 12 
cells, did not have significant effects on «212 replication (Jordan Pepe and Schaffer 
1998).
NGF had the most profound effect on replication of «212. To better hone in on 
what activity was substituting for the absence of ICPO, kinase inhibitors were used that 
could block parts of the NGF-signaling pathway. Inhibitors that could bind more broadly 
reduced replication the most, while more specific inhibitors were less effective. None of 
the inhibitors were able to completely undo the complementing effect of NGF in virus 
production, though K252a a drug capable of inhibiting most NGF pathways came the 
closest to completely blocking the ability of NGF to bolster «212 replication. Taken 
together, these results imply that the ICPO-complementing activity of NGF is due to 
multiple branch points in the NGF pathway not just, for example, the result of an ultimate 
transcription factor activation at the very end of the pathway. The authors of this work 
suggest that this type of activity demonstrated in the PC 12 line may be similar to the type 
of activity that occurs in true neurons and ultimately results in reactivation (Jordan, Pepe 
and Schaffer 1998).
11
Danaher, Jacob, and Miller (1999) successfully established a quiescent HSV-1 
infection in ND-PC12 cells. Their work first details methods of cell culturing that would 
best reduce the population of dividing PC 12 cells that were not as responsive to NGF as 
others, as these cells might serve as reservoirs for a productive infection. To achieve this, 
experiments were done to establish that plating cells in serum-free conditions and NGF 
only could produce a virtually steady number of adherent, differentiated cells for seven 
weeks.
This group modified the protocol of Block et al. (1994) with the addition of 
acycloguanosine (acyclovir, ACV), an inhibitor of HSV-1 DNA replication. Wilcox and 
Johnson (1988) showed that latency could be induced in sympathetic neurons in tissue 
cultured from the superior cervical ganglia of prenatal rats by the use of ACV for 10 
days. Since ND-PC12 cells have a partial sympathetic neuron phenotype, Danaher, Jacob, 
and Miller (1999) thought it appropriate to attempt using ACV.
The result was that after an initial period of productive infection while ACV was 
being included in media (10 days post-infection), there was no detectable virus in culture. 
This result is in contrast to the work of Block et al. (1994). Another contrasting finding of 
this work was the removal of NGF was not sufficient to reactivate the virus as shown by 
Wilcox and Johnson (1988) or increase viral titer as shown by Block et al. (1994).
To confirm the presence of virus in latent form, quiescently infected cultures were 
treated with forskolin, a cAMP activator known to reactivate latent HSV-1 (Smith et al. 
1992). After 38 and 49 days of maintaining suspected quiescently infected (QIF) PC 12 
cultures, forskolin treatments were able to reactivate the virus and produce infectious
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progeny. RT-PCR was also used to detect viral transcripts at different points in the 
timeline of the QIF cultures. RT-PCR analysis showed that all transcripts were reduced 
by 99% 10 days post-infection (upon ACV-withdrawal) except for the LATs which were 
reduced 53%, then remained steady (Danaher, Jacob and Miller 1999).
Another study done by Danaher et al. (1999) presumably in parallel with the 
previous work put the QIF-PC12 model to use by experimenting with heat stress as a 
stimulus for reactivation. It has been shown that transient hyperthermia, a temporary heat 
stress, can lead to FISV-1 reactivation (Halford, Gephart and Carr 1996). QIF-PC12 
cultures were grown and established in the same manner and timing as initially done by 
Danaher, Jacob, and Miller previously (1999). The ability of a heat stress at 43°C for one 
hour to induce reactivation was compared to forskolin treatment.
In terms of the percentages of cultures that were successfully reactivated by both 
forskolin and heat stress, the results were comparable. The main difference seen was that 
heat stress could reactivate the virus more quickly than forskolin. Immunocytochemistry 
was used to detect viral antigens on the surface of cells in order to quantify how many 
cells had reactivating virus, and it was found that a minority were reactivating (one 
immunoreactive focus per 22,000 cells). RT-PCR showed wide scale viral gene induction 
among all members tested from each kinetic class as early as 12 hours post-heat stress 
(Danaher et al. 1999).
An important finding in this work, aside from the demonstration of the QIF-PC12 
model as a viable means of studying latency, was the confirmation that reactivation due
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to heat stress occurs in a minority of cells in vitro, as it also does in vivo (Sawtell and 
Thompson 1992). It is not discussed what could account for this activity.
After Block et al.’s (1994) initial unsuccessful attempt Su et al. (1999) succeeded 
in generating a fully quiescent infection using a different protocol than Danaher, Jacob, 
and Miller (1999). Undifferentiated PC 12 cells were seeded onto poly-L-omithine coated 
flasks. The medium used was RPMI 1640 supplemented with 10% horse serum and 5% 
fetal bovine serum, representing a deviation from the low-serum protocol used by 
Danaher, Jacob, and Miller (1999). Furthermore, an antimitotic agent, 5- 
fluorodoxyuridine (5-flu) was included. The initial week of NGF supplementation would 
allow for all responsive cells to cease division and differentiation. The inclusion of 5-flu 
at day seven for 2-3 days was thought to eliminate any dividing cells that remained. 
Presuming that this technique worked, it would eliminate cells incapable of quiescent 
infection upon addition of virus. After this period, 5-flu was discontinued and NGF was 
maintained in the serum-supplemented medium. A more significant deviation in this 
study that Su et al. claim better represents a naturally simulated latent-like infection was 
the decision to exclude the addition of an anti-viral agent, such as the ACV that Danaher, 
Jacob, and Miller (1999) included in their work.
Su et al. (1999) obtained a similar result as Danaher, Jacob, and Miller (1999) in 
that there was an initial period of productive infection after addition of virus to cultures. 
Su et al. (1999) reported infectious virus produced for 2-3 days after infection and 
speculated that it could be due to the continued presence of mitotic permissive cells that 
were not eliminated by 5-flu, or of some differences among a minority population of cells
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that would release virus then recover. After this period, there was no detectable virus and 
it was reported that the quiescent state had been reached.
To confirm the quiescent state, PCR was done in the thymidine kinase gene of 
HSV-1 in order to search for viral genomes. These experiments confirmed that HSV-1 
DNA was present in ND-PC12 cells in the flask and plaque assays showed that infectious 
virus was not being produced, thus, quiescence had been established. Additionally, 
Southern blot hybridization had been performed and LATs were found in all cultures (Su 
et al).
To put their own QIF-PC12 model to use, Su et al. (1999) experimented with 
introducing subpopulations of different cells into the QIF-PC12 cultures to better 
simulate the heterogeneity of an in vivo environment. Human corneal fibroblasts (HCF) 
were used because of their ability to support productive infection both in vitro and in 
vivo, and also because HCFs are often in contact with the axons of neurons (Dawson and 
Togni 1976; Wander, Centifanto and Kaufman 1980). When HCFs were overlayed onto 
QIF-PC12 cells, they moved under the QIF-PC12 cells while the QIF-PC12 cells 
maintained their morphology. At this time, NGF was removed from medium. When the 
HCFs were added, a productive infection resulted, implying reactivation.
The addition of undifferentiated PC 12 cells and mouse neuroblastomas did not 
reactivate the virus. In addition to the HCFs, monkey kidney CV-1 and human 
hepatoblastoma HepG2 cells were able to stimulate virus production. Cocultivation under 
plaquing conditions demonstrated that reactivation was occurring throughout the QIF- 
PC12 population (Su et al. 1999).
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Superinfection can cause a type of “domino effect” in which the viral products of 
one reactivated cell infect another already quiescently infected cell and stimulate virion 
production, resulting in a type of reactivation cascade. Su et al. (2000) generated a 
recombinant virus that would produce blue plaques to superinfect already established 
QIF-PC12 cells. The reverse process was also carried out whereby wild type virus was 
used to infect QIF-PC12 cultures established with recombinant virus. Results showed that 
neither strain could be reactivated by superinfection with the other. Also, RT-PCR could 
not detect transcripts from any kinetic classes after superinfection indicating that there 
was no de novo gene expression after superinfection (Su et al. 2000).
PCR examination of nuclear and cytoplasmic cell fractions showed that most viral 
DNA was found in the nucleus, as expected, providing basis for the conclusion that the 
lack of reactivation from superinfection is not due to a failure of the superinfecting viral 
DNA to move into the nucleus. When superinfected QIF-PC12 cells were cocultivated 
with the HepG2 cells that were shown to induce viral production in QIF-PC12 cells by Su 
et al. (1999), both plaque phenotypes could be seen, indicating that the recombinant had 
successfully entered the QIF-PC12 and was reactivated just as the wild type was (Su et al. 
2000).
A significant result of this study was the connection made by the researchers that 
the failure of the superinfection to stimulate virus production was more of a result of the 
intracellular environment rather than interference from the existing quiescent viral 
genome. Superinfections were carried out 26 days after differentiation had been begun 
and maintained, as opposed to the initial infection carried out 10 days after the addition of 
NGF. When the researchers differentiated PC 12 cells for 26 days with NGF and then
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began a primary infection, they found similar results as that shown in the superinfection. 
That is, instead of an initial productive phase of new progeny, titers instead dropped very 
quickly. This was associated with virus that was present in the initial inocula that 
persisted through media changes while declining. This implies that the initial period of a 
productive infection may be able to be bypassed by differentiating PC 12 cells with NGF 
for a longer period of time. This new hypothesis is supported by work in vivo that showed 
that neonatal trigeminal ganglia were more permissive to productive infection than adult 
trigeminal ganglia when tissue was excised and infected in vitro (Hay, Gaydos and 
Tenser 1995). Other previous work supporting this hypothesis showed that ICP4 
promoter activity was seen in 100 times more neurons in the trigeminal ganglia of 
newborn mice compared to adults (Mitchell 1995). Unfortunately, this was not 
investigated further in this study (Su et al. 2000).
In a group comprised of members of the Su et al. study (2000), Moxley et al. 
(2002) did work with their QIF-PC12 model that reported a very curious finding. The 
report begins with stating that after about seven weeks, ND-PC12 cells detach from 
culture substrate. While detachment in cell culturing is widely seen as an indication of 
cell death, Moxley et al. (2002) found that the ND-PC12 cells that detached “naturally” 
after 37-54 days had viability of 95%, determined by trypan blue assay. QIF-PC12 cells, 
however, remained attached for 102 days, the duration of the study.
Moxley et al. (2002) attempted to approach this curious finding from different 
angles but were able to gain little insight. They found that LAT null mutants still had the 
detachment-preventing effect, indicating that LAT expression was not central to the 
prevention of detachment. The two different 17 and McKrae wild type strains were both
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used with the same effect, indicating that the phenomenon is not strain-specific. 
Significantly, it was found that viral gene expression was needed in order to facilitate the 
phenomenon. This discovery was made by exposing virus to UV, known to render virions 
deficient in gene expression and new virion production but not adsorption (Schaffer,
Aron and Bemyesh-Meinick 1973). It was found that ND-PC12 cells infected with 
expression-deficient viruses detached by 55 days at rates comparable to uninfected cells, 
while infected cells displayed the detachment-prevention phenomenon. One final test 
showed that viral DNA replication was not needed for the phenomenon, either, though 
this much could have been assumed from knowledge that the virus was in a quiescent 
state (Moxley et al. 2002).
There is a paucity of research on the detachment-prevention phenomenon. Related 
work in sympathetic and trigeminal neurons has shown that transfection with LATs also 
can bolster the survival of neurons when they are deprived of NGF (Hamza et al. 2007). 
The same work showed that LATs also double the regeneration rate of axons and that 
these effects are carried out through the mitogen-activated protein kinase (MAPK) 
pathway. Clearly, work is being done to elucidate the counterintuitive phenomenon of 
viral infection being neuroprotective, but in as much as it applies to the PC 12 system, the 
field has been silent.
Miller et al. (2003) returned to QIF-PC12 investigation with the objective to 
perform correlative analyses between it and in vivo models. Throughout the history of the 
QIF-PC12 cell model it becomes clear that the teams headed by Block were more 
concerned with new information that could come out of the QIF-PC12 model while teams 
headed by Miller focused more on establishing the model for its own sake, as an analogy
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of an in vivo latent infection. This 2003 study followed the pattern, where work was done 
to compare the QIF-PC12 model to an established rabbit eye model of ocular herpes and 
in vivo latency.
Miller et al. (2003) kept their initial protocols, that is, the inclusion of ACV and 
the lack of an antimitotic agent such as the 5-flu used by the experiments done by the 
Block groups. The comparison with the rabbit eye model was carried out by evaluating 
the behavior of two viral constructs, 17+/pR20.5/5 which had an immediate-early gene 
deletion and 17+/pR20.5/5/LAT which had a LAT ORF in place of the deletion, since it 
had been shown that LAT could substitute for the absence of immediate-early activity 
(Thomas 1999). As expected, 17+/pR20.5/5 was replication deficient while 
17+/pR20.5/5/LAT behaved close to levels of wild type. The same results were found 
when the viruses were reactivated from latency. Miller et al. (2003) then produced their 
QIF-PC12 cultures with the viruses and performed the same analyses to both test for the 
viability of the QIF-PC12 model and to see if the reactivation phenotypes of the viruses 
would be similar in ND-PC12 neuronal cells. Results showed that viruses demonstrated 
the same patterns of reactivation in the QIF-PC12 cultures as they did in the rabbit eyes. 
Further data showed that both the in vivo and in vitro models (that is, latently infected 
trigeminal ganglia of rabbits and QIF-PC12 cells, respectively) contained comparable 
numbers of latent viral genomes respective to each viral construct.
Since the QIF-PC12 cells showed different viral constructs expressing the same 
respective reactivation efficiency phenotypes as in the rabbit model, researchers 
concluded the QIF-PC12 model was a suitable complement to the in vivo model. The 
heterogeneity of other cell types in the in vivo model is both positive and negative: on one
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hand it represents the natural environment that the virus will reactivate in and it is likely 
that contact and communication with other cell types plays a role in latency and 
reactivation. On the other hand, studying such events and interactions on a cellular and 
molecular basis is difficult to do with tissue samples. This is what makes the QIF-PC12 
model complementary as opposed to supplementary, in that it does allow for close 
cellular and molecular analysis, provided it can be continually shown that the model 
behaves similarly to in vivo models. In this analysis, such a demonstration was 
successfully done (Miller et al. 2003).
Miller, Danaher, and Jacob (2006) used a number of different mutant viral 
constructs with either gene deletions or insertions, and employed recombinant adenovirus 
vectors constructed to overexpress different HSV-1 genes with QIF-PC12 cells. The 
mutants were as follows: R7910 bearing an ICPO deletion and derived from F strain 
(Kawaguchi, Van Sant and Roizman 1997), KD6 bearing an ICP4 deletion and derived 
from KOS strain (Dobson et al. 1990), ml 814 bearing a 12-bp insertion that disrupts 
VP16’s transactivating domain and derived from 17+ strain, KM 100 a construct virus 
derived from both KOS and 17+ containing a mutation rendering ICPO nonfunctional 
(same mutation found in mutant n212) and the same VP 16 mutation of ml 814, V422 
another VP 16 mutant with the entire C-terminal acidic domain of VP 16 truncated 
(Mossman 1999), and KM110 bearing both the n212 ICPO mutation and the V422 VP 16 
truncation. The genes used in the adenovirus vectors were as follows: origin-binding 
protein (OBP), gD, ICPO, ICP4, VP 16, the 2.6 kb LAT, a mutated nonfunctional ICPO, 
and a mutated nonfunctional VP 16. For trans expression studies, quiescent infections 
were established using strains KOS and 17+ in order to compare differential reactivation
20
phenotypes. QIF-PC12 cultures established with each strain were subsequently 
superinfected with adenovirus expression vectors. For mutant studies, QIF-PC12 cultures 
were then established with the viral constructs and reactivation stressors forskolin, TSA, 
or heat stress were used to assess reactivation efficiency from all different strains and 
constructs. Reactivation efficiency was measured as # cultures harboring live virus# 
total cultures x 100%.
The trans expression studies were used to test the major transcriptional activators, 
ICPO, ICP4, and VP 16 to see if overexpression of any single one could stimulate 
reactivation in QIF-PC12 cells. Strain 17+ showed differential reactivation, responding 
more efficiently to the ICPO vector than to VP 16 or ICP4. KOS had similar reactivation 
after exposure to each vector. Infection with vectors containing OBP (an early gene), gD 
(a late gene), LAT, or the mutant ICPO or VP 16 did not induce reactivation above 
background levels seen in this study. Results taken together showed that overexpression 
of any of the three major transcriptional activators could reactivate the virus in QIF-PC12 
cultures, and that there was a stark contrast in the involvement of ICPO in reactivation 
between 17+ and KOS strains, showing a molecular basis for differential reactivation 
phenotypes that exist among HSV-1 strains (Miller, Danaher and Jacob 2006).
In mutant studies also done within this work, there was an interesting observation. 
The ICPO deletion mutant R7910 reactivated more efficiently in response to forskolin and 
heat stress than did its parent F strain. In response to TSA, however, R7910 reactivated 
just above basal levels while F strain had greater than 3-fold reactivation efficiency. This 
implies a differential pathway of reactivation for TSA than either heat stress or forskolin 
treatment. The ICP4 deletion mutant KD6 failed to reactivate after exposure to all
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stresses. When QIF-PC12 cultures created with KD6 were superinfected with the 
adenovirus vector expressing ICP4, reactivation did occur. These data together indicate 
that ICPO is not required in reactivation from stimuli that apparently work on different 
pathways, but ICP4 is an absolute requirement for any type of reactivation event to occur, 
at least at the level for which it could be detected by viral plaque assays. The VP 16 
insertion mutant m l814 was then used to establish QIF-PC12 cultures along with its 
parent strain 17+. Not only was this mutant able to reactivate following the three stresses, 
but another differential reactivation phenotype was seen in that TSA was an efficient 
inducer or reactivation in both viruses, approaching nearly 100% efficiency as compared 
to the 21% efficiency seen in F strain and 8% in F strain’s derivative R7910 (Miller, 
Danaher and Jacob 2006).
Since reactivation was seen in both ICPO deletion and VP 16 mutants, KM 100, a 
virus containing both the ICPO deletion and the m l814 VP 16 mutation was used to see 
the effect of the absence of both ICPO and VP 16 activities. The result was that 
reactivation occurred in response to all stresses, but was most efficient following heat 
stress at about 50% reactivation, as compared to forskolin and TSA, both treatments 
inducing reactivation in approximately 30% of cultures (Miller, Danaher and Jacob 
2006).
An interesting result was seen with V422, the virus containing a VP 16 whose 
acidic C-terminal domain was completely truncated. V422 was not able to reactivate 
above the spontaneous levels seen in control cultures in response to the reactivation 
stresses. The same result was found using KM110, a virus containing a mutation in ICPO 
and the V422 VP 16 truncated mutation. These results imply that the mutation of VP 16 in
22
m l814 does not completely inhibit VP16’s transactivating activity, the acidic C-terminal 
domain is required for transactivation in reactivation, and VP 16 itself must be necessary 
for stress-induced reactivation (Miller, Danaher and Jacob 2006).
In summary, this study revealed many important details about the interaction of 
HSV-1 and ND-PC12 cells: ICPO is not needed in reactivation, ICP4 is essential, and 
VP 16 is essential only in stress-induction (Miller, Danaher and Jacob 2006).
Aiamkitsumrit et al. (2007) conducted investigations using a mutant virus within 
the context of the QIF-PC12 model. This worked focused on the role that anti-apoptotic 
pathways modulated by HSV-1 genes play in infection. The virus used was dl20, derived 
from strain KOS, lacking the ICP4 gene and bearing a defective US3 gene (DeLuca, 
McCarthy and Schaffer 1985). The US3 gene functions to prevent apoptosis in infected 
cells (Benetti, Munger and Roizman 2003; Benetti and Roizman 2004; Jerome et al.
1999) . Virus dl20 defective in US3 has been shown to be very cytotoxic, causing 
apoptosis in mitotic cell lines: Vero, SK-N-SH, Hep-2, and HEL (Galvan, Brandimarti 
and Roizman 1998; Galvan and Roizman 1999; Leopardi and Roizman 1996; Leopardi, 
Van Sant and Roizman 1997; Munger, Chee and Roizman 2001; Zhou and Roizman
2000)  .
Aiamkitsumrit et al. (2007) sought to determine the extent of involvement of 
nuclear factor (NF)-kB in HSV-1 infection of neurons, and thus used ND-PC12 cells. 
Although this work did not explicitly deal with a quiescent infection, the conditions under 
which the cells were cultured were identical to those used by Su et al. (1999). The true 
goal of maintaining the initial period of NGF-differentiation in this work, however, was
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not to achieve quiescence but to bypass an initial but transient approximate seven day 
period in which it was reported that NF-kB was transiently activated in PC 12 cells after 
exposure to NGF (Azoitei, Wirth and Baumann 2005). The interest in NF-kB 
involvement stems from a previous hypothesis that NF-kB could allow for viral DNA 
replication (Amici et al. 2004, Gregory et al. 2004, et al. Patel 1998) and demonstrations 
that NF-kB could possibly be involved in pro- or anti-apoptotic pathways (Goodkin, Ting 
and Blaho 2003; Taddeo et al. 2003; 2004; Yedowtiz and Blaho 2005).
Since the previous studies were only done on dividing cells, Aiamkitsumrit et al. 
(2007) experimented with ND-PC12 cells to see how dl20 behaved. The first observation 
noted was that, just as seen by Su et al. in 2002, infection with dl20 prevented the 
detachment of cells from culture flasks. A difference was seen in the duration of 
detachment in that dl20-infected cells detached earlier than wild-type KOS-infected 
cells. Nearly 100% of KOS-infected cells remained attached at day 45 as compared to 
approximately 50% if dl20-infected cells seen at the same time. Cells infected with dl20 
still remained attached for longer than uninfected cells.
It was also seen that dl20 failed to induce apoptosis in ND-PC12 cells. Parallel 
infections were carried out with Vero cells and confirmation of apoptosis as a result of 
infection was seen (Aiamkitsumrit et al. 2007).
In assessing for the involvement of NF-kB in dl20-mediated apoptosis, Western 
blotting of cytoplasmic and nuclear cell fractions was carried out on p65. Even though 
p65 was confirmed to be present in the ND-PC12 cells, infection by both KOS and dl20
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did not show its translocation from cytosol to nucleus, indicating a failure to activate the 
NF-kB pathway (Fuseler et al. 2006).
The report was the first to demonstrate a failure of d 120 to cause apoptosis in a 
cell line. This finding paired with the group’s earlier finding demonstrating that linear 
viral DNA has a much higher half-life in ND-PC12 cells than it does in dividing cells (30 
days in ND-PC12 vs. 3 days in dividing cells; Su et al. 2002).
Danaher et al. (2008) sought to perform microarray analysis on QIF-PC12 cells to 
determine differences in gene expression as compared to mock infected cells. Results 
were validated with real-time PCR. A total number of 9,064 genes of R. norvegicus were 
analyzed with 1,427 being significantly altered in expression by quiescent infection. 
Those that were most upregulated (greater than 3-fold) were KEGG pathways that were 
significantly associated with QIF-activated genes (ranged from 1.13- to 2.15-fold 
upregulated), genes involved in significant molecular functions (ranged from 1.59- to 
6.51-fold upregulated), and genes that were at least 50% repressed (ranged from to 0.29- 
to 0.50-fold downregulated). Results showed only few patterns. Genes that were most 
upregulated by quiescent infection were those involved in proteolysis and in 
collagen/axonal remodeling. Expectedly, genes that were most downregulated were those 
involved in apoptosis, as well as ion transport and cGMP biosynthesis.
The PC 12 cell system represents a viable alternative to tissue explant models in 
studying latency. When parallel in vivo studies were undertaken, data derived from 
experiments with tissue expiants were very similar to that of the PC 12 in vitro system.
PC 12 cells provide for a readily replenishable and homogeneous source of cultured cells
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that are appropriate for neuronal studies. However, it must still be considered that 
differences among neuronal phenotypes may produce misleading results. NGF and its 
signaling pathways may be the cornerstones in validating the PC 12 model, linking the 
sympathetic neuronal phenotype to the sensory neuronal phenotype.
The highlight of the QIF-PC12 model is that virus can be reactivated and 
recovered by stimuli known to reactivate virus in vivo. It would be difficult to suggest 
that the molecular events that transpire as a result are very different in sympathetic 
neurons than in sensory neurons, but this possibility cannot be ruled out.
When latency is examined in the context of the PC 12 system, there is an overall 
lack of experimentation with small molecule drugs. The convenience of the QIF-PC12 
system will allow for the use of inhibitor drugs to better study enzymatic events in the 
switch from latency to reactivation. Among the many foreseeable applications of a 
successful HSV-1 latency model, one of them is the possible mediation of latency and 
reactivation through small molecule inhibitors. The conundrum posed by HSV-1 is that it 
is a lifelong infection in neurons. Inducing wide-scale apoptosis of infected neurons by 
either using a Double-stranded RNA [dsRNA] Activated Caspase Oligomerizer 
(DRACO) (Rider et al. 2011) or inducing the immune system to recognize and attack 
latently infected cells may solve the infection problem but result in undesirable loss of a 
largely non-dividing cell population that could lead to a clinical loss of sensation. Normal 
antiviral drug therapies may succeed in reducing, but not eliminating reactivation events, 
yet spare the host cells of destruction. The best approach may be one that has a longer 
and wider scope of focus, specifically in finding better inhibitors of reactivation in the 
presence of reactivation stimuli for use at the patient level, followed by a robust and
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vigilant public health initiative at the population level that will reduce the number of 
infections in succeeding generations. Herpesviruses in general are widely accepted as 
having coevolved with humans very successfully. Overcoming such challenges requires 




Adherent rat pheochromocytoma (PC 12) cells and African green monkey kidney (Vero) 
cells were acquired from ATCC, Manassss, VA (Adh-PC12 Cat# CRL-1721.1; Vero 
Cat# CCL-81). PC 12 cells were propagated in DMEM containing 10% horse serum (HS) 
and 5% fetal bovine serum (FBS) in tissue culture treated flasks. Vero cells were 
propagated in DMEM containing 5% FBS in tissue cultured treated flasks. All media 
were supplemented with gentamicin at 100 pg/ml. Cells were incubated at 37°C and 7.5% 
CO2 . PC 12 cells were scraped and split 1:4 every 3 days. Vero cells were trypsinized and 
split 1:5 every 5 days. Virus GHSV-UL46 was purchased from ATCC, Manassas, VA 
(VR-1544). Viral stocks were prepared by passaging through Vero cells and then stored 
in -80 °C.
PC 12 Differentiation
PC 12 cells were seeded on collagen I-coated 24-well plates at a density of 29,000 
cells/cm2 in DMEM containing 1% HS and 0.5% FBS. Cells were allowed 24 hours to 
attach. Mouse 2.5S nerve growth factor (NGF) (Becton Dickinson, cat# 356004) was 
subsequently added to media at 100 ng/ml. Media was changed every 3 days thereafter 
and henceforth included NGF. On day 7 post-plating, the anti-mitotic 5- 
fluorodeoxyuridine (5-flu) was added at a concentration of 20 pM to eliminate cells not
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responsive to NGF. 5-flu was discontinued thereafter. Differentiation was confirmed by 
microscopic visualization of neurite outgrowths.
Reagents
On Day 10 post-plating, the following reagents were included in media replenishments: 
acycloguanosine (acyclovir, ACV)(Sigma-Aldrich CAS# 59277-89-3) at 100 pM, 
roscovitine (Rosco)(SelleckBio, cat #S 1153) at 100 pM, PD98059 (PD)(SelleckBio cat# 
SI 177) at 20 pM, or a combination rosco 100 pM + PD 20 pM treatment. Reagents were 
maintained in media atevery replenishment thereafter. Phosphate-buffered saline (PBS) 
(Sigma-Aldrich P4593) was diluted from lOx stock provided down to lx  (.01M 
phosphate buffer, .0154M sodium chloride) and supplemented with gentamicin at 100 
pg/ml.
ND-PC12 Infection
Eleven days post-plating, infection using GHSV-UL46 at MOI 3 was carried out by first 
aspirating all media then adding 100 pi of virus to each well on a 24-well plate. Plates 
were incubated for 1 hour at 37°C with intermittent rocking of plates every 15 minutes. 
Excess virus was then aspirated and fresh media containing reagents was added.
Vero monolayer infection
For all instances of infections using Vero cell monolayers, Vero cells were propagated in 
tissue culture-treated 6-well plates and maintained as described. Upon reaching
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confluence, media were aspirated. For inhibitor studies using Vero cells, 500 pL of viral 
stock was added to each well of 6-well plates. For assessment of viral presence in ND- 
PC12 cultures, 500 pL of ND-PC12 media from cultures was added to each well of Vero 
cells. After the addition of stock/media, plates were incubated in 37°C and 7.5% CO2 for 
1 hour with intermittent rocking of plates every 15 minutes. Excess virus/media were 
aspirated, fresh Vero media were added, and cells were incubated at 37°C and 7.5% CO2 
for 48 hours, after which point apoptosis and cytopathic effect were assessed for visually.
Fluorescence microscopy
Analysis of cultures and detection of EGFP was carried out using a Motic AE30/31 
fluorescence microscope set to FITC with a 494 nm excitation wavelength and a 518 nm 
emission wavelength. Images were recorded using a digital microscope ocular camera 
with USB data transfer to an HP Pavillion laptop.
Cell culture stresses
Combination heat and starvation stresses were carried out concurrently by first replacing 
media of infected ND-PC12 cultures with PBS. No sera, nutrients, or other growth factors 
were added. Inhibitor drugs were maintained in respective cultures. After replacing with 
PBS, cultures were incubated at 41°C, 7.5% CO2 for 24 hours. After the 24 hour period of 
heat stress, cultures were transferred to a 37°C incubator, 7.5% CO2 , and remained in PBS 
without change or replenishment.
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RESULTS
The ICPO activity inhibitor Rosco was assessed for its ability impact latency of 
GHSV-UL46 in ND-PC12 cells. It has been shown that inhibition of cdk5 via Rosco 
causes apoptosis in cortical neurons and slows/lessens the phenotypic differentiation of 
PC 12 cells by NGF via sustained overactivity of MEK1 (Zheng et al. 2007). A specific 
MEK1 inhibitor, PD98059 (PD), was shown to rescue neurons from the detrimental 
effects of Rosco (Zheng et al. 2007). Rosco and PD were added individually or together 
to ND-PC12 cells or Vero cells 1 day prior to infection (11 days post-plating and NGF- 
differentiation for PC 12 cells). ACV was added for comparison.
Vero cells were infected with GHSV-UL46 at an MOI of 3 in the presence of 
inhibitors. After 48 hours, direct microscopic examination of cultures for cytopathic 
effect (CPE) was carried out using an inverted microscope. After the addition of GHSV- 
UL46, CPE was seen in virtually 100% of cells without inhibitor treatments (Figure 1 A). 
Treatments of Vero cells with ACV showed virtually complete protection from CPE and 
the maintenance of a confluent monolayer (Figure IB). The individual addition of both 
inhibitors, Rosco and PD, showed a differential effect on cell cultures. Rosco-treated 
cultures showed more CPE as compared to ACV-treated cultures, but less than untreated 
cultures as roughly 5-10% of cells remained attached (Figure 1C). PD did not appear to 
have any effect on Vero cultures (Figure ID) and is comparable to the result seen in 
Figure 1A with no treatments added. The combination treatments of Rosco and PD 
(Figure IE) showed results similar to those seen with the singular addition of Rosco. 
Figure IF is included as an NGF control to show it has no antiviral effect. All inhibitors
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were added to parallel cultures of uninfected Vero cells to screen for unexpected 
detachment from substrate; none was seen (Figure 1).
Figure 1. Inverted microscope images of Vero cells 72 hours after infection with GHSV-UL46,100X. A.) No treatment 
B.) ACV C.) Rosco D.) PD E.) Rosco + PD F.) NGF
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ND-PC12 cells were differentiated as previously described and infected at MOI of 
3. One day prior to infection, inhibitors were included in media and for every 
replenishment thereafter. Seven days after infection, assessment of viral production was 
made using fluorescence microscopy and inoculation of Vero monolayers with infected 
ND-PC12 media using Vero apoptosis as positive confirmation of the presence of 
infectious virus.
Figure 2 shows the results of fluorescence imaging. Undifferentiated PC 12 cells 
did not thrive in low-serum medium and persisted at low numbers in culture (Figure 2A). 
Uninfected ND-PC12 cells thrived under low-serum conditions supplemented with NGF 
(Figure 2B). In concordance with earlier work done on the QIF-PC12 model, 
differentiation with NGF resulted in an approximately 40-50% decrease in cell number 
followed by a period in which cell number was maintained (Block et al. 1994). 
Unexpectedly, fluorescence was still seen where ACV was added, as well as Rosco 
(Figures 2D and 2E, respectively). When PD was included as the only treatment, no 
visible fluorescence was observed (Figure 2F). The combination treatment of Rosco and 
PD showed a return to fluorescence, but less noticeable than all other positive results. 
(Figure 2E). When media from infected ND-PC12 as well as Vero cultures was used to 
inoculate Vero cell monolayers, data obtained correlated directly with results obtained 
from inverted and fluorescence microscope imagery with the exception of the culture 
subjected to PD that did not show fluorescence (Figure 2F). A summary of the combined 
results seen is presented (Table 1, Figure 2).
Figure 2. Fluorescence microscope pictures taken 10 days post-infection (All 100X, except 2B. 400X) A.) 
Undifferentiated, uninfected PC 12 cells B.) Uninfected ND-PC12 cells C.) Infected ND-PC12 cells, 
untreated D.) ACV-treated infected ND-PC12 cells E.) Rosco-treated infected ND-PC12 cells F.) PD- 
treated infected ND-PC12 cells G.) Rosco+PD-treated infected ND-PC12 cells
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Table 1. Media from indicated cell cultures subjected to treatments tested on Vero cell monolayers; positive 
or negative for presence o f  infectious virus by detection o f  CPE in Vero cells.
It has been repeatedly seen that a productive infection results for at least 10 days 
after infection with HSV-1 in ND-PC12 cells (Block et al. 1994; Danaher, Jacob and 
Miller 1999). This was the case with GHSV-UL46 as well, as evidenced by using lysate 
to inoculate monolayers of Vero cells and monitoring for CPE as positive confirmation of 
virus presence. After 10 days, it was still seen that all ND-PC12 cultures were still 
producing virus. Since it has been previously shown that some, but not all, wild-type 
HSV-1 infected ND-PC12 cells do undergo low-level spontaneous reactivation 
throughout the infectious cycle (Danaher et al. 1999) and that on some occasions, low- 
level activity continues indefinitely (Block et al. 1994), environmental stressors were 
applied despite the absence of a truly quiescent infection due to their ability to increase 
virus production regardless of the state of infection (Block et al. 1994; Danaher et al. 
1999). Heat stress and NGF-deprivation have been individually shown to reactivate a 
high number of QIF-PC12 cultures (Danaher et al. 1999, Block et al. 1994, respectively), 
and NGF was seen to be inhibitory to reactivation (Feib et al. 1991). The heat stress used 
in the referenced work was carried out at 43° C for 3 hours. For this study, the heat stress 
was tempered down to 41°C and lengthened in duration to 24 hours. These criteria were
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used to better simulate the febrile conditions that are widely known to reactivate herpes 
simplex viruses in clinical situations (Epstein 1941), which presumably led earlier 
medical professionals to term the telltale herpetic skin lesions “fever blisters.” Since it 
has already been shown that a different ICP4 deletion mutant, KD6, did not reactivate 
after heat stress, and that differential pathways of reactivation may exist that respond to 
different types of stimuli (Miller, Danaher and Jacob 2006), the second reactivation 
stimulus was included in the form of nutrient- and NGF-deprivation through complete 
starvation of cultures of both sera and media. Applying both these stresses 
simultaneously was used to test for a synergistic activation of differential reactivation 
pathways.
In the case of uninfected ND-PC12 cells, 24 hours of heat stress under starvation 
conditions produced the expected result of complete detachment from culture wells 
(Figure 3 A). Figure 3 A is a representative image of untreated, uninfected cells, but in all 
other cases in which uninfected cells were subjected to treatments, the results of 
detachment of all cells and loss of neural morphology were the same. However, in all 
cultures that had been previously exposed to GHSV-UL46, attached cells persisted 
regardless of treatment applied or withheld (Figures 3B-3F). Differences in morphology 
can be seen in Rosco treated infected cells (Figure 3D), consistent with the previously 
documented loss of morphology ND-PC12 cells experience after long-term exposure to 
Rosco (Zheng et al. 2007), but ND-PC12 cells still remained attached. There was a 
notable decrease in cell density (~40-50%) and detached cells were present, but a large 
number of attached, intact cells remained. Densities of infected cell cultures post-heat
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stress (Figure 3) can be compared to those of pre-heat stress uninfected and infected cell 
cultures previously shown (Figure 2B and 2C, respectively, Figure 3).
Figure 3. Inverted microscope images o f ND-PC12 cells after 24 hour heat stress. A.) Uninfected, untreated 
cells B.) Infected, untreated cells C.) ACV treated infected cells D.) Rosco treated infected cells E.) PD 
treated infected cells F.) Rosco+PD treated infected cells
Post-heat stress virion production was tested for by once again transferring lysates 
from infected ND-PC12 cultures to monolayers of Vero cells. CPE was seen in all 
cultures of Vero cells exposed to lysates, though not to the extent as seen in Figure 1A 
where a known MOI of 3 was used to infect. These results are identical to those obtained 
prior to heat stress.
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DISCUSSION
The purpose of this study was to examine the suggestion made by Liu et al.
(2010) that a repressor/anti-repressor relationship may exist between the viral products 
ICPO and ICP4 and that this relationship may have significant implications for latency. 
Small molecule inhibitors were used in order to narrow the field of possibilities for the 
molecular events that take place. Data gained from the use of inhibitors implicate host 
cell cdk’s and members of the MAPK pathway as potentially significant players in the 
molecular events that mediate the switch from latent to productive infection and vice 
versa.
Data indicates that a quiescent infection did not take place during the course of 
this study. The previous work done on establishing a QIF-PC12 model shows that one of 
two outcomes can result from infecting ND-PC12 cells with HSV-1: 1.) a quiescent state 
devoid of new virion production and lowered gene expression, save for spontaneous 
reactivation (Danaher, Jacob and Miller 1999) or 2.) a low-level, long-term productive 
infection (Block et al. 1994). The use of ACV, an inhibitor of the viral thymidine kinase, 
has been shown to be an optional addition in the establishment of the quiescent infection 
and not necessary (Su et al. 1999).
ACV was shown to be a potent inhibitor of viral productive infection in Vero 
cells, where minimal CPE was seen as a result of infection from GHSV-UL46 (Figure 
IB). Images taken from a light microscope of the infected Vero cells treated with ACV 
do show some detached cells. This could be as a result of naturally-occurring cell 
detachment during the incubation period as cell density nears confluence, or due to a less 
than 100% inhibition of viral replication by ACV. The latter possibility is considered
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more likely and more consistent with the imagery. Identical conditions of infection and 
ACV treatment in ND-PC12 cells showed a low-level productive infection inferred by 
fluorescent activity seen via fluorescence microscope imagery (Figure 2D). It is 
important to note that the fluorescence is mostly seen in the center of cell clusters. Such 
close clustering of cells may have prevented adequate diffusion of ACV into cells in the 
center of the cluster and caused a failure to prevent viral replication. To support this 
reasoning, fluorescent activity can be seen more uniformly throughout untreated infected 
ND-PC12 cells irrespective of differential cell density (Figure 2C).
Similar contradictory results between Vero and ND-PC12 cells were seen when 
Rosco was used as a treatment. Rosco appeared to have a small protective effect on Vero 
cells (Figure 1C) but did not impact the establishment of latency of induction of 
reactivation in ND-PC12 cells as evidenced by fluorescence seen in cells (Figure 3E) and 
infection of Vero cells induced by lysates (Table 1). One explanation for this may be that 
NGF affects the promoters of HSV-1 IE genes. In HSV-1 infected ND-PC12 cells 
displaying a low-level productive infection, NGF upregulates ICPO 4-fold (Block et al. 
1994). The concentration of Rosco used in this study was 100 pM, based on previous 
work that showed this concentration as adequate for inhibition of ICPO activity in 
dividing cells not known to be responsive to NGF (Davido, Leib and Schaffer 2002). If 
ICPO levels are quadrupled in NGF-responsive cells as suggested by Block et al. (1994), 
then this concentration of Rosco may be insufficient to inhibit ICPO activity. Since long­
term exposure to the 100 pM Rosco concentration is detrimental to ND-PC12 cells 
without the aid of PD (Zheng et al. 2007), a corresponding 4-fold increase in Rosco 
concentration to match the upregulated levels of ICPO may contribute additional
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challenges, however, combinations of Rosco and PD should be experimented with further 
to assess for the specific likelihood of this outcome.
The possibility that the levels of Rosco used in this study were overwhelmed by 
NGF-stimulated ICPO activity is further supported. In work done with ICPO deletion 
mutants infecting ND-PC12 cells, NGF was seen to have an ICPO-complementing ability 
sufficient enough to return new virion production in cells infected by ICPO mutants to 
near-wild type levels (Jordan, Pepe and Schaffer 1998). The combination of NGF’s ICPO- 
complementing activity as well as its ability to upregulate ICPO itself may have more 
than overwhelmed any inhibitory effect Rosco was having within the ICPO pathway. 
However, if it can be shown that Rosco concentrations can be safely increased with the 
help of PD, valuable information could be obtained on the ICPO pathway. If using Rosco 
does not halt or hinder production of new viral proteins, it would be reasonable to 
conclude that the mechanism by which NGF complements ICPO is not the mechanism by 
which Rosco enacts its inhibitory effects, namely, the phosphorylation of an ICPO-like 
signaling protein or transcription factor by cdk5. Cdk5 could thusly be ruled out as a 
major player in the ICPO pathway inasmuch as it applies to latency.
As mentioned, PD was included as a prophylactic treatment to mitigate the loss of 
neural morphology of ND-PC12 cells after exposure to Rosco. PD is a highly specific 
inhibitor of MEK1 and, to a lesser extent, MEK2 (Sharma et al. 2002). At the outset of 
NGF-stimulated differentiation of PC12 cells, MEK1 is required for the initiation of 
neurite outgrowth, but is active for only a short period of time (1-2 hours) until cdk5 
levels rise (Sharma et al. 2002). The phosphorylation of MEK1 by cdk5 inactivates 
MEK1 and allows ND-PC12 cells to survive in a non-mitotic state while maintaining
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neural morphology (Zheng et al. 2007). Visual inspection of neuritic outgrowth across 
ND-PC12 cultures showed the expected difference among cultures treated with Rosco 
alone vs. Rosco and PD together.
Unexpectedly, PD controls showed the most contrasting results. The effects of PD 
with or without Rosco showed the greatest difference with little to no fluorescence in 
ND-PC12 cells (Figures 2F and 2G) but no protection from CPE in Vero cells (Figure 
ID). The positive confirmation of virus in PD-treated cultures seen from infecting Vero 
monolayers with lysates could have been due to residual virus, or a level of infection too 
low for fluorescent detection yet sufficient enough to produce infectious virions. In the 
ICPO deletion mutant studies previously mentioned, it was seen that treatment with PD 
negated approximately 50% of the NGF-complemented stimulation of the virus (Jordan, 
Pepe and Schaffer 1998). It is possible that PD may partially negate the NGF-stimulated 
upregulation of ICPO, enough to shift equilibrium towards latency and produce the results 
shown here. However, the results of experiments done with combination Rosco and PD 
treatments still show low-level virus activity; albeit at a lower degree than other cultures 
(Figure 3G). One possible implication is that the effects of Rosco and PD are antagonistic 
to each other. The previously referenced report of PD negating the NGF-complemented 
replication of ICPO by only 50% demonstrates that other pathways exist that either work 
additively or synergistically to fully complement ICPO activity. Indeed, it was shown that 
the broader the spectrum of kinase inhibition that a drug could achieve, the more negation 
that was seen. Since the use of Rosco would not only inhibit cdk5, but also cdkl and 
cdk2 (Meijer et al. 1997), it may be of value to consider that the effects of inhibition of 
these kinases may work to promote viral replication in non-mitotic cells.
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The low level inhibition of viral replication by Rosco in Vero cells may imply a 
degree dependence on cdkl, cdk2, or cd5 during a fully productive infection. This 
dependence could be thought to be an identically persisting factor during infection in 
ND-PC12 cells, but the results of the Rosco and PD combination treatments would imply 
otherwise. Treatment with PD appears to halt a low-level productive infection in ND- 
PC12 cells to the point of non-detection by fluorescence, but has no effect during a fully 
productive infection in Vero cells. Differential activity of MEK1 and possibly MEK2 is 
suggested by these findings. The substrates acted upon by MEK1 and MEK2 could prove 
to be very valuable candidates for future investigations into latency and reactivation in 
neuronal cells. A suitable starting candidate may be found in MYC, a downstream 
transcription factor in the MAPK pathway (Nagai et al. 1997) that has been shown to be 
upregulated 2.57 times more in QIF-PC12 cells than uninfected ND-PC12 cells (Danaher 
et al. 2008).
The restoration to low-level productivity when Rosco and PD are used 
simultaneously suggests that the roles of ckdl, cdk2, and/or cdk5 may be different during 
infection in ND-PC12 cells versus Vero cells. ICPO has 11 different phosphorylation sites 
phosphorylated either by HSV-1 ’s own UL13 or host kinases (Davido et al. 2005). It is 
possible that the activity of ICPO can be finely adjusted by different combinations of 
phosphorylation in such a way as to not only affect ICPO’s transactivating activity, but 
also its potential to bind other proteins such as ICP4. Interestingly, the expression 
analysis carried out in QIF-PC12 cells showed that among the genes most repressed by 
an FISV-1 quiescent infection was cyclin-dependent kinase inhibitor IB (CDKN1B; 
Danaher et al. 2008), whose product binds to and inhibits the activity of cdk2 and cdk4
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(Polyak et al. 1994). It was found to be repressed to a level of 0.69 of that found in 
parallel uninfected ND-PC12 cultures (Danaher et al. 2008). Additionally, ICPO has been 
shown to bind cyclin D3 and in this way inactivate cdk4 and cdk6 (Kalamvoki and 
Roizman 2009). Taken together these data could imply that HSV-1 achieves its own 
manipulation, monitoring, and control of its life cycle by downregulating certain host 
processes in order to make its own processes more sensitive to stimuli.
In the context of the ICP0-ICP4 hypothesis, the findings shown here may suggest 
that inhibition of ICPO activity by preventing its phosphorylation by cdkl, cdk2, and 
cdk5 does not substitute for the suggested downregulation of ICPO by ICP4 since it did 
not produce a quiescent infection. Since a quiescent infection was not achieved, the 
ability for GHSV-UL46 to reactivate in the presence of different inhibitors could not be 
tested. Since Rosco inhibits the phosphorylation of ICPO in a very specific way, it is 
unknown if other phosphorylation events go on that go towards or against the 
establishment of quiescence. Because ICPO is still present in the cell at normal or higher 
levels, the possibility that it complexes with other proteins and enacts other effects when 
doing so still remains.
While it has been documented in the past that infection with different strains of 
HSV-1, including dl20 from which GHSV-UL46 is directly derived, results in a 
protective effect on ND-PC12 cells in the form of preservation of neural morphology and 
prevention of detachment from culture flasks (Aiamkitsumrit et al. 2007; Moxley et al. 
2002), this is the first report showing that the extreme conditions of prolonged heat stress 
coinciding with complete starvation of sera and nutrients did not abate this protective 
effect. Cultures of uninfected cells, regardless of presence or absence of any treatments,
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were virtually all detached from culture wells upon viewing, 24 hours after heat stress. A 
very small minority of loosely attached cells showed cytopathy and a complete loss of 
neural morphology (Figure 3A). The only difference among infected cultures after heat 
stress was that Rosco-treated cultures showed a slight decrease in neural morphology, as 
expected (Figure 3D). Positive confirmation of virus presence was seen in all cultures by 
infection of Vero monolayers with ND-PC12 lysates.
The methodology shown here of using a fluorescent virus that is only visualized 
during a productive infection and a convenient neuronal-like cell model is suitable for the 
study of latency in HSV-1. A key component to this design is the EGFP attached to the 
tegument protein of GHSV-UL46. That quality renders the virus ideal for the study of 
latency, since fluorescence necessarily implies a productive infection. The PC 12 model 
provides renewable and homogeneous source of cells for which to study either a low- 
level productive or quiescent infection. The results shown here demonstrate that there are 
clear differences in responses to inhibitors in the contexts of fully productive and low- 
level productive infections. The use of small molecule inhibitors is a convenient way to 
find suitable molecular candidates for future investigation, especially significant in 
elucidating the molecular events of latency and reactivation. Future explorations using 
this experimental model would greatly benefit from the inclusion of fluorescent plate 
reading technology. Measuring fluorescence in addition to viewing it would provide for 
an objective method of quantifying viral productivity, latency, and reactivation. Numbers 
garnered from plate reader data could then be correlated to viral titers, and patterns then 
examined. The unique benefit of using GHSV-UL46 with the PC 12 model could be 
capitalized by the engineering of a strain of quiescently infected, undifferentiated (and
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thus actively dividing) PC 12 cells similar to the NC37 strain of human cord blood 
lymphocytes that are latently infected with Esptein-Barr virus (Fresen et al. 1980). 
Although one group has reported that the removal of NGF from media increases virion 
production during a low-level productive infection in ND-PC12 cells (Block et al. 1994), 
work has also been done showing that removing NGF from media of true QIF-PC12 cell 
cultures does not result in reactivation (Danaher, Jacob, and Miller 1999), and it is known 
that ND-PC12 cells reverse their phenotypes and dedifferentiate back into mitotic form 
after prolonged NGF deprivation (Greene and Tischler 1976). Furthermore, since ICP4 
mutants have been shown to fail to reactivate (Miller, Danager and Jacob 2006), 
engineering such a PC 12 strain using GHSV-UL46 may also reveal more mechanisms of 
latency and reactivation. Whether a quiescently infected, dividing strain of PC 12 cells 
could be achieved or not, the results of such an endeavor would certainly be rewarding.
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